AAAAAA

   
Results: 1-8 |
Results: 8
MODULATION OF IMMUNOLOGICAL RESPONSES TO HIV-1(MN) RECOMBINANT GP160 VACCINE BY DOSE AND SCHEDULE OF ADMINISTRATION
Authors: GORSE GJ MCELRATH MJ MATTHEWS TJ HSIEH RH BELSHE RB COREY L FREY SE KENNEDY DJ WALKER MC EIBL MM
Citation: Gj. Gorse et al., MODULATION OF IMMUNOLOGICAL RESPONSES TO HIV-1(MN) RECOMBINANT GP160 VACCINE BY DOSE AND SCHEDULE OF ADMINISTRATION, Vaccine, 16(5), 1998, pp. 493-506
SAFETY PROFILE OF PHASE-I AND PHASE-II PREVENTIVE HIV TYPE-1 ENVELOPEVACCINATION - EXPERIENCE OF THE NIAID AIDS VACCINE EVALUATION GROUP
Authors: KEEFER MC WOLFF M GORSE GJ GRAHAM BS COREY L CLEMENTSMANN ML VERANIKETTER N ERB S SMITH CM BELSHE RB WAGNER LJ MCELRATH MJ SCHWARTZ DH FAST P CHARRON K REYNOLDS MJ ZIMMERMAN E JONES K HARRIS M FREY SE KENNEDY DJ ISRAEL H BERRY C READ B SPITZ T PACATTE T DOLIN R REICHMAN RC LAMBERT J DEMETER L ROBERTS NJ PUGLIESE M BERGER D BURKE J SCOTT T BLACKSTONE E WRIGHT PF BRAEUNER M RYBCZYK GK CRUMBO K BATTLE W CORNELL R OWENS D JENNINGS M HARBISON MA HENSMAN BJ BARR P STABLEIN DM VOSS T PALLAS S LOMAX N KOFF W LAWRENCE D JOHNSTON M SAVARESE B WESCOTT SL
Citation: Mc. Keefer et al., SAFETY PROFILE OF PHASE-I AND PHASE-II PREVENTIVE HIV TYPE-1 ENVELOPEVACCINATION - EXPERIENCE OF THE NIAID AIDS VACCINE EVALUATION GROUP, AIDS research and human retroviruses, 13(14), 1997, pp. 1163-1177
A DOSE-RANGING STUDY OF A PROTOTYPE SYNTHETIC HIV-1(MN) V3 BRANCHED PEPTIDE VACCINE
Authors: GORSE GJ KEEFER MC BELSHE RB MATTHEWS TJ FORREST BD HSIEH RH KOFF WC HANSON CV DOLIN R WEINHOLD KJ FREY SE KETTER N FAST PE
Citation: Gj. Gorse et al., A DOSE-RANGING STUDY OF A PROTOTYPE SYNTHETIC HIV-1(MN) V3 BRANCHED PEPTIDE VACCINE, The Journal of infectious diseases, 173(2), 1996, pp. 330-339
TREATMENT OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS INFECTION WITH QUINUPRISTIN DALFOPRISTIN
Authors: TORRALBA MD FREY SE LAGGING LM
Citation: Md. Torralba et al., TREATMENT OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS INFECTION WITH QUINUPRISTIN DALFOPRISTIN, Clinical infectious diseases, 21(2), 1995, pp. 460-461
HIV-1 RECOMBINANT GP160 VACCINE-INDUCED ANTIBODIES IN SERUM AND SALIVA
Authors: GORSE GJ ROGERS JH PERRY JE NEWMAN FK FREY SE PATEL GB BELSHE RB SCHWARTZ DH CLEMENTS ML KEEFER M DOLIN R MCELRATH J COREY L GRAHAM BS WRIGHT PF STABLEIN DM MATTHEWS TJ BOLOGNESI D MESTECKY J WALKER MC FAST PE
Citation: Gj. Gorse et al., HIV-1 RECOMBINANT GP160 VACCINE-INDUCED ANTIBODIES IN SERUM AND SALIVA, Vaccine, 13(2), 1995, pp. 209-214
VACCINE-INDUCED ANTIBODIES TO NATIVE AND RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS
Authors: GORSE GJ FREY SE PATEL G NEWMAN FK BELSHE RB SCHWARTZ D CLEMENTS ML KEEFER M ROBERTS N DOLIN R MCELRATH J COREY L GRAHAM BS WRIGHT P MATTHEWS T BOLOGNESI D WALKER MC FAST P FERNIE BF
Citation: Gj. Gorse et al., VACCINE-INDUCED ANTIBODIES TO NATIVE AND RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS, Vaccine, 12(10), 1994, pp. 912-918
HIV-1 RECOMBINANT GP160 VACCINE GIVEN IN ACCELERATED DOSE SCHEDULES
Authors: GORSE GJ SCHWARTZ DH GRAHAM BS MATTHEWS TJ STABLEIN DM FREY SE BELSHE RB CLEMENTS ML WRIGHT PF EIBL M FAST PE
Citation: Gj. Gorse et al., HIV-1 RECOMBINANT GP160 VACCINE GIVEN IN ACCELERATED DOSE SCHEDULES, Clinical and experimental immunology, 98(2), 1994, pp. 178-184
EXPRESSION OF SOLUBLE, ACTIVE HUMAN MCP-1 IN THE CYTOPLASM OF AN ESCHERICHIA-COLI TRXB STRAIN
Authors: FREY SE WELCH PK MCCABE DD FOX D GEORGE HJ PATTERSON TA
Citation: Se. Frey et al., EXPRESSION OF SOLUBLE, ACTIVE HUMAN MCP-1 IN THE CYTOPLASM OF AN ESCHERICHIA-COLI TRXB STRAIN, The FASEB journal, 7(7), 1993, pp. 1296-1296
Risultati: 1-8 |